Article Data

  • Views 312
  • Dowloads 148

Original Research

Open Access

Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy

  • A. Gadducci1,*,
  • A. Ferrero2
  • R. Tana1
  • M.G. Fabrini3
  • P. Modaffari2
  • A. Fanucchi1
  • C. Vignati1
  • P. Zola2

1Department of Procreative Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy

2Department of Gynecology and Obstetrics, University of Turin, Mauriziano Hospital, Turin, Italy

3Department of Oncology, Division of Radiation Oncology, University of Pisa, Pisa, Italy

DOI: 10.12892/ejgo201206640 Vol.33,Issue 6,November 2012 pp.640-643

Published: 10 November 2012

*Corresponding Author(s): A. Gadducci E-mail: a.gadducci@obgyn.med.unipi.it

Abstract

Purpose of investigation: To assess the outcome of patients with squamous cell vulvar carcinoma treated with deep partial or total vulvectomy and inguinal-femoral lymphadenectomy. Materials and Methods: The authors assessed 87 patients who underwent primary surgery. Results: Tumor recurred in 34 patients, and the first relapse was local in 19, inguinal in ten, and distant in five. Five-year disease-free survival was 56.7% and was related to Stage (p < 0.0001), grade (p = 0.023), and node status (p < 0.0001). Groin failure occurred in 4.9% of node-negative patients compared with 29.6% of node-positive patients (p = 0.0096). Distant recurrences only developed in women with positive nodes. Among the 47 patients who underwent bilateral lymphadenectomy and who had negative nodes, groin recurrence occurred in 12% of those who had <= 15 nodes removed and 0% of those who had > 15 nodes removed. Conclusions: Stage and node status were the most important prognostic variables. There was a trend favoring a better groin control in patients with node-negative disease who underwent extensive lymphadenectomy.

Keywords

Vulvar carcinoma; Prognosis; Recurrence; Survival; Inguinal-femoral lymphadenectomy

Cite and Share

A. Gadducci,A. Ferrero,R. Tana,M.G. Fabrini,P. Modaffari,A. Fanucchi,C. Vignati,P. Zola. Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy. European Journal of Gynaecological Oncology. 2012. 33(6);640-643.

References

[1] Podratz K.C., Symmonds R.E., Taylor W.F., Williams T.J.: “Carcinoma of the vulva: analysis of treatment and survival”. Obstet. Gynecol., 1983, 61, 63.

[2] Homesley H.D., Bundy B.N., Sedlis A., Adcock L.: “Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes”. Obstet. Gynecol., 1986, 68, 733.

[3] Thomas G.M., Dembo A.J., Bryson S.C.P., Osborne R., DePetrillo A.D.: “Changing concepts in the management of vulvar cancer”. Gynecol. Oncol., 1991, 42, 9.

[4] Gadducci A., Cionini L., Romanini A., Fanucchi A., Genazzani A.R.: “Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer”. Crit. Rev. Oncol. Hematol., 2006, 60, 227.

[5] Burke T.W., Stringer C.A., Gershenson D.M., Edwards C.L., Morris M., Wharton J.T.: “Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva”. Gynecol. Oncol., 1990, 38, 328.

[6] Siller B.S., Alvarez R.D., Conner W.D., McCullough C.H., Kilgore L.C., Partridge E.E. et al.: “T2/3 vulva cancer: case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy”. Gynecol. Oncol., 1995, 57, 335.

[7] Leminen A., Forss M., Paavonen J.: “Wound complications in patients with carcinoma of the vulva. Comparison between radical and modified vulvectomies”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2000, 93, 193.

[8] Dhar K.K., Woolas R.P.: “Changes in the management of vulval cancer”. Best. Pract. Res. Clin. Obstet. Gynaecol., 2003, 17, 529.

[9] Van der Zee A.G., Oonk M.H., De Hullu J.A., Ansink A.C., Vergote I., Verheijen R.H. et al.: “Sentinel node dissection is safe in the treatment of early-stage vulvar cancer”. J. Clin. Oncol., 2008, 26, 884.

[10] Homesley H.D., Bundy B.N., Sedlis A., Yordan E., Berek J.S., Jahshan A. et al.: “Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study)”. Gynecol. Oncol., 1993, 49, 279.

[11] Maggino T., Landoni F., Sartori E., Zola P., Gadducci A., Alessi C. et al.: “Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study”. Cancer, 2000, 89, 116.

[12] Lataifeh I., Nascimento M.C., Nicklin J.L., Perrin L.C., Crandon A.J., Obermair A.: “Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva”. Gynecol. Oncol., 2004, 95, 701.

[13] Beller U., Quinn M.A., Benedet J.L., Creasman W.T., Ngan H.Y., Maisonneuve P. et al.: “Carcinoma of the vulva”. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynecol. Obstet., 2006, 95 (Suppl. 1), S7.

[14] Gadducci A., Tana R., Barsotti C., Guerrieri M.E., Genazzani A.R.: “Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva”. Crit. Rev. Oncol. Hematol., 2012, 83, 71.

[15] Origoni M., Sideri M., Garsia S., Carinelli S.G., Ferrari A.G.: “Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva Stage III and IVA FIGO”. Gynecol. Oncol., 1992, 45, 313.

[16] Paladini D., Cross P., Lopes A., Monaghan J.M.: “Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva”. Cancer, 1994, 74, 2491.

[17] van der Velden J., van Lindert A.C., Lammes F.B., ten Kate F.J., Sie-Go D.M., Oosting H. et al.: “Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival”. Cancer, 1995, 75, 2885.

[18] Raspagliesi F., Hanozet F., Ditto A., Solima E., Zanaboni F., Vecchione F. et al.: “Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva”. Gynecol. Oncol., 2006, 102, 333.

[19] Fons G., Hyde S.E., Buist M.R., Schilthuis M.S., Grant P., Burger M.P. et al.: “Prognostic value of bilateral positive nodes in squamous cell cancer of the vulva”. Int. J. Gynecol., 2009, 19, 1276.

[20] Le T., Elsugi R., Hopkins L., Faught W., Fung-Kee-Fung M.: “The definition of optimal inguinal femoral nodal dissection in the management of vulva squamous cell carcinoma”. Ann. Surg. Oncol., 2007, 14, 2128.

[21] Stehman F.B., Ali S., DiSaia P.J.: “Node count and groin recurrence in early vulvar cancer: A Gynecologic Oncology Group study”. Gynecol. Oncol., 2009, 113, 52.

[22] Courtney-Brooks M., Sukumvanich P., Beriwal S., Zorn K.K., Richard S.D., Krivak T.C.: “Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease?”. Gynecol. Oncol., 2010, 17, 308.

[23] Micheletti L., Preti M., Zola P., Zanotto Valentino M.C., Bocci C. et al.: “A proposed glossary of terminology related to the surgical treatment of vulvar carcinoma”. Cancer, 1998, 83, 1369.

[24] Lavie O., Comerci G., Daras V., Bolger B.S., Lopes A., Monaghan J.M.: “Thrombocytosis in women with vulvar carcinoma”. Gynecol. Oncol., 1999, 72, 82.

[25] Hacker N.F.: “Revised FIGO staging for carcinoma of the vulva”. Int J. Gynaecol. Obstet., 2009, 105, 105.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top